AV
Atlas Venture Opportunity Fund II, L.P.
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Atlas Venture Opportunity Fund II, L.P.. Director active across 3 companies, notably Korro Bio, Inc.. Aggregated, 21 filings have been published. Activity tracked since 22 June 2026. The latest transaction was filed on 14 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Atlas Venture Opportunity Fund II, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
6,602 股@ US$13.81Common StockSEC144:0001628280-26-061897
1,750 股@ US$13.060.012% mcap1.2% 占其流量Common StockSEC144:0001628280-26-061592
759 股@ US$79.370.0020% mcap24.3% 占其流量Common StockSEC144:0001628280-26-060747
2,339 股@ US$80.050.0061% mcap75.7% 占其流量Common StockSEC144:0001628280-26-060505
51 股@ US$13.730.0004% mcap0.0% 占其流量Common StockSEC144:0001628280-26-059121
4,884 股@ US$13.220.032% mcap3.4% 占其流量Common StockSEC144:0001628280-26-058029
478,377 股@ US$25.960.26% mcap51.9% 占其流量CommonSEC144:0001628280-26-057188
94,415 股@ US$26.170.050% mcap21.5% 占其流量CommonSEC144:0001628280-26-056844
368 股@ US$13.490.0025% mcap0.3% 占其流量Common StockSEC144:0001628280-26-055859
77,387 股@ US$22.840.045% mcap37.6% 占其流量CommonSEC144:0001628280-26-047532
8,506 股@ US$14.000.058% mcap8.5% 占其流量Common StockSEC144:0001628280-26-047351
127,182 股@ US$23.070.075% mcap62.4% 占其流量CommonSEC144:0001628280-26-047355
14,745 股@ US$13.650.095% mcap15.8% 占其流量Common StockSEC144:0001628280-26-046980
51,756 股@ US$20.940.022% mcap14.5% 占其流量CommonSEC144:0001628280-26-046096
81,903 股@ US$20.610.035% mcap22.7% 占其流量CommonSEC144:0001628280-26-045820
6,382 股@ US$20.330.0027% mcap1.5% 占其流量CommonSEC144:0001628280-26-045613
7,093 股@ US$13.710.048% mcap5.5% 占其流量Common StockSEC144:0001628280-26-045301
25,397 股@ US$20.260.011% mcap5.8% 占其流量CommonSEC144:0001628280-26-045297
17,426 股@ US$13.900.12% mcap13.7% 占其流量Common StockSEC144:0001628280-26-044983
39,131 股@ US$20.870.017% mcap9.2% 占其流量CommonSEC144:0001628280-26-044987
3,661 股@ US$12.990.023% mcap2.7% 占其流量Common StockSEC144:0001628280-26-044737
About Atlas Venture Opportunity Fund II, L.P.
Atlas Venture Opportunity Fund II, L.P. is a shareholder of Dyne Therapeutics, Inc. and Korro Bio, Inc. The declarant has 12 filings in total, and across the 12 recent filings covered, they correspond to sales of EUR 8,449,574, with a modal transaction nature of notice of proposed sale (Form 144), between 2026-06-22 and 2026-07-07.